Retraction note: Preclinical analysis of the anti-tumor and anti-metastatic effects of Raf265 on colon cancer cells and CD26+ cancer stem cells in colorectal carcinoma (Molecular Cancer, (2015), 14, 1, (80), 10.1186/s12943-015-0352-y)

  • Ariel K.M. Chow
  • , Nathan S.M. Cheng
  • , Colin S.C. Lam
  • , Lui Ng
  • , Sunny K.M. Wong
  • , Timothy M.H. Wan
  • , Johnny H.W. Man
  • , Alvin H.K. Cheung
  • , Thomas C.C. Yau
  • , Jensen T.C. Poon
  • , Wai Lun Law
  • , Roberta W.C. Pang

Research output: Contribution to journalComment/debate

Abstract

The Editor-in-Chief has retracted this article. A number of image integrity concerns were raised after publication. Specifically: two panels in Fig. 4B, HT29 Saline and Raf265, appear to overlap with two panels of Fig. 5B Anti-CD31 of a previously published paper [1]. two panels in Fig. 4B, HTC116 Saline and Raf265, appear to overlap with two panels of Fig. 5A Anti-CD31 in the same previously published paper [1]. The authors have not responded to correspondence about these concerns. The Editor-in-Chief has lost confidence in the data and conclusions of this article. Author Ariel Chow disagrees with this retraction. All other authors have not responded to correspondence regarding this retraction.

Original languageEnglish
Article number302
JournalMolecular Cancer
Volume24
Issue number1
DOIs
Publication statusPublished - Dec 2025
Externally publishedYes

Fingerprint

Dive into the research topics of 'Retraction note: Preclinical analysis of the anti-tumor and anti-metastatic effects of Raf265 on colon cancer cells and CD26+ cancer stem cells in colorectal carcinoma (Molecular Cancer, (2015), 14, 1, (80), 10.1186/s12943-015-0352-y)'. Together they form a unique fingerprint.

Cite this